{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:14:33Z","timestamp":1762506873072},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>The goal of this study was to retrospectively evaluate the clinical impact of an accurate autocorrecting blood glucose monitoring system in children with severe burns. Blood glucose monitoring system accuracy is essential for providing appropriate intensive insulin therapy and achieving tight glycemic control in critically ill patients. Unfortunately, few comparison studies have been performed to evaluate the clinical impact of accurate blood glucose monitoring system monitoring in the high-risk pediatric burn population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective analysis of an electronic health record system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Pediatric burn ICU at an academic medical center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Children (aged &lt; 18 yr) with severe burns (\u2265 20% total body surface area) receiving intensive insulin therapy guided by either a noncorrecting (blood glucose monitoring system-1) or an autocorrecting blood glucose monitoring system (blood glucose monitoring system-2).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Patient demographics, insulin rates, and blood glucose monitoring system measurements were collected. The frequency of hypoglycemia and glycemic variability was compared between the two blood glucose monitoring system groups. A total of 122 patient charts from 2001 to 2014 were reviewed. Sixty-three patients received intensive insulin therapy using blood glucose monitoring system-1 and 59 via blood glucose monitoring system-2. Patient demographics were similar between the two groups. Mean insulin infusion rates (5.1\u2009\u00b1\u20093.8\u2009U\/hr; <jats:italic toggle=\"yes\">n<\/jats:italic> = 535 paired measurements vs 2.4\u2009\u00b1\u20091.3\u2009U\/hr; <jats:italic toggle=\"yes\">n<\/jats:italic> = 511 paired measurements; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001), glycemic variability, and frequency of hypoglycemic events (90 vs 12; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001) were significantly higher in blood glucose monitoring system-1\u2013treated patients. Compared with laboratory measurements, blood glucose monitoring system-2 yielded the most accurate results (mean \u00b1 <jats:sc>sd<\/jats:sc> bias: \u20131.7\u2009\u00b1\u20096.9\u2009mg\/dL [\u20130.09\u2009\u00b1\u20090.4 mmol\/L] vs 7.4\u2009\u00b1\u200913.5\u2009mg\/dL [0.4\u2009\u00b1\u20090.7 mmol\/L]). Blood glucose monitoring system-2 patients achieve glycemic control more quickly (5.7\u2009\u00b1\u20094.3 vs 13.1\u2009\u00b1\u20096.9\u2009hr; <jats:italic toggle=\"yes\">p<\/jats:italic>&lt; 0.001) and stayed within the target glycemic control range longer compared with blood glucose monitoring system-1 patients (85.2% \u00b1 13.9% vs 57.9% \u00b1 29.1%; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Accurate autocorrecting blood glucose monitoring system optimizes intensive insulin therapy, improves tight glycemic control, and reduces the risk of hypoglycemia and glycemic variability. The use of an autocorrecting blood glucose monitoring system for intensive insulin therapy may improve glycemic control in severely burned children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000000877","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T16:56:07Z","timestamp":1470761767000},"page":"e406-e412","source":"Crossref","is-referenced-by-count":16,"title":["Clinical Impact of Accurate Point-of-Care Glucose Monitoring for Tight Glycemic Control in Severely Burned Children*"],"prefix":"10.1097","volume":"17","author":[{"given":"Nam K.","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary R.","family":"Godwin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda N.","family":"Steele","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina L.","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Division of Burn Surgery, Department of Surgery, University of California Davis School of Medicine, Shriners Hospital for Children of Northern California, Sacramento, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/01.ta.0000188933.16637.68","article-title":"Impact of tight glycemic control in severely burned children.","volume":"59","author":"Pham","year":"2005","journal-title":"J Trauma"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005373-199802000-00019","article-title":"Effects of insulin on wound healing.","volume":"44","author":"Pierre","year":"1998","journal-title":"J Trauma"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"S476","DOI":"10.1097\/01.CCM.0000278066.05354.53","article-title":"Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance.","volume":"35","author":"Cree","year":"2007","journal-title":"Crit Care Med"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/rccm.201002-0190OC","article-title":"Intensive insulin therapy in severely burned pediatric patients: A prospective randomized trial.","volume":"182","author":"Jeschke","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/BCR.0b013e31829b3700","article-title":"Clinical impact of sample interference on intensive insulin therapy in severely burned patients: A pilot study.","volume":"35","author":"Tran","year":"2014","journal-title":"J Burn Care Res"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients.","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa1204942","article-title":"Hypoglycemia and risk of death in critically ill patients.","volume":"367","author":"Finfer","year":"2012","journal-title":"N Engl J Med"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/193229681000400201","article-title":"Regulatory controversies surround blood glucose monitoring devices.","volume":"4","author":"Klonoff","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/dc06-1679","article-title":"Glucose measurement: Confounding issues in setting targets for inpatient management.","volume":"30","author":"Dungan","year":"2007","journal-title":"Diabetes Care"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/15209150050194215","article-title":"Oxygen effects on glucose measurements with a reference analyzer and three handheld meters.","volume":"2","author":"Tang","year":"2000","journal-title":"Diabetes Technol Ther"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.5858\/2000-124-1135-EODHLO","article-title":"Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing.","volume":"124","author":"Tang","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5858\/2000-124-0577-EOPOGM","article-title":"Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing.","volume":"124","author":"Tang","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00003246-200105000-00038","article-title":"Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing.","volume":"29","author":"Tang","year":"2001","journal-title":"Crit Care Med"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1089\/dia.2014.0074","article-title":"Retrospective evaluation of the accuracy of Roche AccuChek Inform and Nova StatStrip glucose meters when used on critically ill patients.","volume":"16","author":"Karon","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/193229680900300612","article-title":"Glycemic control in the burn intensive care unit: Focus on the role of anemia in glucose measurement.","volume":"3","author":"Mann","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/193229681000400317","article-title":"Continuous glucose monitors and the burden of tight glycemic control in critical care: Can they cure the time cost?","volume":"4","author":"Signal","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/193229681200600615","article-title":"Evaluation of a continuous blood glucose monitoring system using central venous microdialysis.","volume":"6","author":"Schierenbeck","year":"2012","journal-title":"J Diabetes Sci Technol"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201609000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T23:06:23Z","timestamp":1692831983000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201609000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000000877","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}